IOL Chemicals & Pharmaceuticals Ltd Share Price
Last Updated Date: 27 Aug 2026
₹193.05
+7.00 (+3.76%)
As of 28 Aug 2026, IOL Chemicals & Pharmaceuticals Ltd share price is ₹193.05. The stock opened at ₹193.05 and had closed at ₹186.05 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹67.14 and a high of ₹187.50. In terms of performance, IOL Chemicals & Pharmaceuticals Ltd share price has increased by 158.36% over the past six months and has increased by 112.73% over the last year.
IOLCP Charts
IOL Chemicals & Pharmaceuticals Ltd Overview
Market cap₹5,667 Crs
Volume7,30,932
Prev. Close₹186.05
Year range₹67.14 - ₹187.50
Total Value₹14,11,06,422.60
ISININE485C01029
About IOLCP
IOL Chemicals & Pharmaceuticals is engaged in the manufacturing and selling of Pharmaceutical and Chemical products.
IOL Chemicals & Pharmaceuticals Ltd Historical Performance
1 Month Return27.26%
6 Month Return164.45%
3 Year Return151.33%
3 Month Return46.98%
1 Year Return110.41%
5 Year Return73.40%
IOL Chemicals & Pharmaceuticals Ltd Fundamental Analysis
ROCE(TTM)10.29%
P/E Ratio (TTM)33.69
P/B Ratio3.15
Debt to Equity0.08
ROE7.66%
EPS (TTM)6.02
Dividend Yield0.52%
Book Value61.27
Profit Margin7.00%
Operating Margin9.06%
IOL Chemicals & Pharmaceuticals Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 764.44 | 621.19 | 585.68 | 574.41 | 559.06 |
| EBITDA | 111.73 | 94.31 | 51.35 | 63.98 | 69.52 |
| Net Profit | 64.48 | 53.18 | 20.58 | 30.00 | 33.96 |
| EPS | 2.20 | 1.81 | 0.70 | 1.02 | 1.16 |
IOL Chemicals & Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 71.34 |
| MACD | 5.93 |
| 20-Day SMA | 162.38 |
IOL Chemicals & Pharmaceuticals Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
IOL Chemicals & Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of IOL Chemicals & Pharmaceuticals Ltd today is ₹193.05 on NSE and ₹193.05 on BSE.
- The 52-week high of IOL Chemicals & Pharmaceuticals Ltd is ₹187.50, while the 52-week low is ₹67.14.
- The current market capitalisation of IOL Chemicals & Pharmaceuticals Ltd is approximately ₹5,667 crore.
- The P/E (Price-to-Earnings) ratio of IOL Chemicals & Pharmaceuticals Ltd is 17.76. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of IOL Chemicals & Pharmaceuticals Ltd is 1.18. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in IOL Chemicals & Pharmaceuticals Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for IOL Chemicals & Pharmaceuticals Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, IOL Chemicals & Pharmaceuticals Ltd has delivered a return of approximately 151.33%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of IOL Chemicals & Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 62.28% promoters, 4.85% FIIs, 0.43% DIIs, and 26.95% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
